Valens Semiconductor Exceeds Q1 Revenue & EBITDA Guidance, Projects Q2 Growth
VLN has more than doubled off its 52-week low of $1.1 on elevated volume (2.2× avg).
Summary
Valens Semiconductor reported Q1 2026 results exceeding revenue and adjusted EBITDA loss guidance, alongside Q2 revenue guidance indicating sequential growth.
Key Events · Earnings and Guidance · VLN
-
Q1 2026 Revenue Exceeds Guidance
Reported Q1 2026 revenues of $16.9 million, surpassing the top end of guidance ($16.3-$16.7 million), though down from $19.4 million in Q4 2025.
-
Adjusted EBITDA Loss Better Than Expected
Q1 2026 adjusted EBITDA loss was $(5.5) million, better than the guided range of $(7.9)-$(7.5) million.
-
Q2 2026 Revenue Guidance Indicates Growth
Provided Q2 2026 revenue guidance of $17.2 million to $17.6 million, suggesting sequential growth from Q1.
-
Cash Position Declines
Cash, cash equivalents, and short-term deposits stood at $86.1 million as of March 31, 2026, down from $92.6 million at the end of Q4 2025.
Analysis · VLN · Manufacturing
Valens Semiconductor reported first-quarter results that surpassed its own guidance for revenue, gross margin, and adjusted EBITDA loss. While the company continues to operate at a net loss and experienced a sequential decline in revenue, the beat against expectations and the forecast for sequential revenue growth in Q2 provide a degree of positive momentum. The cash balance continues to decline, indicating ongoing burn, but remains at a level that provides runway.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 30.2% of the 1644 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.49%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, VLN was trading at $2.56 on NYSE in the Manufacturing sector, with a market capitalization of approximately $284.3M. The 52-week trading range was $1.10 to $3.34. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.